Literature DB >> 16309379

Physiological matrix metalloproteinase concentrations in serum during childhood and adolescence, using Luminex Multiplex technology.

Kathryn M Thrailkill1, Cindy S Moreau, Gael Cockrell, Pippa Simpson, Rajiv Goel, Paula North, John L Fowlkes, Robert C Bunn.   

Abstract

Matrix metalloproteinases are a family of zinc-dependent proteinases which are involved in the breakdown and remodeling of extracellular matrix. As children grow and adolescents reach pubescence, their bodies undergo changes that require age-related morphogenesis of the extracellular matrix, possibly requiring unique patterns of matrix metalloproteinase (MMP) expression during periods of rapid tissue growth (i.e., childhood) or accelerated tissue remodeling and expansion (i.e., adolescence). Therefore, we have characterized age-specific and gender-specific differences in circulating concentrations of MMPs (specifically MMP-1, -2, -3, -8 and -9) in 189 serum samples obtained from healthy subjects, aged 2-18 years. MMP concentrations were measured using Fluorokine MultiAnalyte Profiling kits and a Luminex Bioanalyzer, as well as by commercial ELISA. Serum levels of MMP-1, -2, -3, -8, and -9 in healthy pediatric subjects represent log-normal distributions. MMP-2 was significantly negatively correlated with age (r=-0.29; p<0.001), while MMP-3 was significantly positively correlated with age (r=0.38; p<0.001). Although plasma, not serum, is considered the appropriate blood sample for measurement of MMP-8 and -9, serum levels of MMP-8 and -9 were also found to be highly positively correlated with each other (r=0.76; p<0.01). MMP results obtained by Fluorokin MultiAnalyte Profiling methods correlated well with conventional ELISA methods and use of this technology provided several advantages over ELISA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16309379      PMCID: PMC2239010          DOI: 10.1515/CCLM.2005.238

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  42 in total

Review 1.  Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors.

Authors:  J E Fata; A T Ho; K J Leco; R A Moorehead; R Khokha
Journal:  Cell Mol Life Sci       Date:  2000-01-20       Impact factor: 9.261

Review 2.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

Review 3.  Multiplexed particle-based flow cytometric assays.

Authors:  D A Vignali
Journal:  J Immunol Methods       Date:  2000-09-21       Impact factor: 2.303

4.  Relaxin increases secretion of tissue inhibitor of matrix metalloproteinase-1 and -2 during uterine and cervical growth and remodeling in the pig.

Authors:  Judy A Lenhart; Peter L Ryan; Kathleen M Ohleth; Stephen S Palmer; Carol A Bagnell
Journal:  Endocrinology       Date:  2002-01       Impact factor: 4.736

5.  Insulin like growth factor-1 selectively regulates the expression of matrix metalloproteinase-2 in malignant H-ras transformed cells.

Authors:  A Yoon; R A Hurta
Journal:  Mol Cell Biochem       Date:  2001-07       Impact factor: 3.396

6.  Altered expression of extracellular matrix and proteinases in Noble rat prostate gland after long-term treatment with sex steroids.

Authors:  S C Li; G F Chen; P S Chan; H L Choi; S M Ho; F L Chan
Journal:  Prostate       Date:  2001-09-15       Impact factor: 4.104

7.  Expression of cathepsins B, H, K, L, and S and matrix metalloproteinases 9 and 13 during chondrocyte hypertrophy and endochondral ossification in mouse fracture callus.

Authors:  H Uusitalo; A Hiltunen; M Söderström; H T Aro; E Vuorio
Journal:  Calcif Tissue Int       Date:  2000-11       Impact factor: 4.333

8.  Human growth hormone stimulates proteinase activities of rabbit bone cells via IGF-I.

Authors:  R Anne-Valérie; D Christelle; F Yannick; P Norbert; P Marc; H Dominique
Journal:  Biochem Biophys Res Commun       Date:  2000-02-24       Impact factor: 3.575

9.  Tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) distribution in normal and pathological human bone.

Authors:  S Bord; A Horner; C A Beeton; R M Hembry; J E Compston
Journal:  Bone       Date:  1999-03       Impact factor: 4.398

10.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

View more
  17 in total

1.  Physiological matrix metalloproteinase (MMP) concentrations: comparison of serum and plasma specimens.

Authors:  Kathryn Thrailkill; Gael Cockrell; Pippa Simpson; Cynthia Moreau; John Fowlkes; R Clay Bunn
Journal:  Clin Chem Lab Med       Date:  2006       Impact factor: 3.694

2.  Injectable Macroporous Hydrogel Formed by Enzymatic Cross-Linking of Gelatin Microgels.

Authors:  Shujie Hou; Rachel Lake; Shiwha Park; Seth Edwards; Chante Jones; Kyung Jae Jeong
Journal:  ACS Appl Bio Mater       Date:  2018-10-15

3.  Circulating matrix metalloproteinases in adolescents with hypertrophic cardiomyopathy and ventricular arrhythmia.

Authors:  Justin P Zachariah; Steven D Colan; Peter Lang; John K Triedman; Mark E Alexander; Edward P Walsh; Charles I Berul; Frank Cecchin
Journal:  Circ Heart Fail       Date:  2012-05-24       Impact factor: 8.790

4.  Plasma metalloproteinase levels are dysregulated in signal transducer and activator of transcription 3 mutated hyper-IgE syndrome.

Authors:  Vibhav Sekhsaria; Lori E Dodd; Amy P Hsu; Jennifer R Heimall; Alexandra F Freeman; Li Ding; Steven M Holland; Gulbu Uzel
Journal:  J Allergy Clin Immunol       Date:  2011-08-27       Impact factor: 10.793

5.  Disease and gender-specific dysregulation of NGAL and MMP-9 in type 1 diabetes mellitus.

Authors:  Kathryn M Thrailkill; Cynthia S Moreau; Gael E Cockrell; Chan-Hee Jo; Robert C Bunn; Alba E Morales-Pozzo; Charles K Lumpkin; John L Fowlkes
Journal:  Endocrine       Date:  2010-01-12       Impact factor: 3.633

6.  Assessment of potential cross-reactivity of human endogenous matrix metalloproteinases with collagenase Clostridium histolyticum antibodies in human sera obtained from patients with Dupuytren's contracture.

Authors:  Thomas J Edkins; Roland Koller-Eichhorn; Jack A Alhadeff; Ulrich Mayer; Heinrich Faust; Benjamin J Del Tito
Journal:  Clin Vaccine Immunol       Date:  2012-02-22

7.  Association of circulating matrix metalloproteinases with carotid artery characteristics: the Atherosclerosis Risk in Communities Carotid MRI Study.

Authors:  John W Gaubatz; Christie M Ballantyne; Bruce A Wasserman; Max He; Lloyd E Chambless; Eric Boerwinkle; Ron C Hoogeveen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-02-18       Impact factor: 8.311

8.  The influence of sex and BMI on cartilage metabolism biomarkers in patients after anterior cruciate ligament injury and reconstruction.

Authors:  Kazandra M Rodriguez; Michael T Curran; Riann M Palmieri-Smith
Journal:  J Athl Train       Date:  2021-09-20       Impact factor: 3.824

9.  Matrix metalloproteinase-2 dysregulation in type 1 diabetes.

Authors:  Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen F Kemp; John L Fowlkes
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

10.  Blood Biomarkers of Chronic Inflammation in Gulf War Illness.

Authors:  Gerhard J Johnson; Billie C S Slater; Linda A Leis; Thomas S Rector; Ronald R Bach
Journal:  PLoS One       Date:  2016-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.